2021 | Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 years | JOURNAL OF DIABETES AND ITS COMPLICATIONS |
2020 | Elevated testosterone increases risk of hepatocellular carcinoma in men with chronic hepatitis B and diabetes mellitus | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2020 | A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy | JOURNAL OF VIRAL HEPATITIS |
2020 | Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic Hepatitis B Virus Infection | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2020 | Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion
| JOURNAL OF HEPATOCELLULAR CARCINOMA |
2020 | Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease | LIVER INTERNATIONAL |
2020 | Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
| CANCERS |
2020 | Serial Transient Elastography Examinations to Monitor Patients With Type 2 Diabetes: A Prospective Cohort Study | HEPATOLOGY |
2020 | Serum hepatitis B core-related antigen predicts hepatocellular carcinoma in hepatitis B e antigen-negative patients | JOURNAL OF GASTROENTEROLOGY |
2020 | Thiazolidinediones reduce the risk of hepatocellular carcinoma and hepatic events in diabetic patients with chronic hepatitis B | JOURNAL OF VIRAL HEPATITIS |
2020 | Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis B | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2020 | Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus
| GUT AND LIVER |
2020 | Entecavir and tenofovir on renal function in patients with hepatitis B virus-related hepatocellular carcinoma | JOURNAL OF VIRAL HEPATITIS |
2020 | Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation
| CANCERS |
2020 | Large-scale genome-wide association study identifies HLA class II variants associated with chronic HBV infection: a study from Taiwan Biobank | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2020 | One world, one pandemic, many guidelines: management of liver diseases during COVID-19
| GUT |
2020 | Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC
| JHEP REPORTS |
2020 | How does low-level viremia affect the prognosis of patients with chronic hepatitis B?
| CLINICAL AND MOLECULAR HEPATOLOGY |
2020 | An optimized hepatocellular carcinoma prediction model for chronic hepatitis B with well-controlled viremia | LIVER INTERNATIONAL |
2020 | How do genetic variants affect our interpretation of non-invasive tests for non-alcoholic fatty liver disease? | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2020 | Reassessing the accuracy of PAGE-B-related scores to predict hepatocellular carcinoma development in patients with chronic hepatitis B | JOURNAL OF HEPATOLOGY |
2020 | Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib for Advanced Hepatocellular Carcinoma: A Prospective Phase 2 Trial | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2020 | Unresolved issues of immune tolerance in chronic hepatitis B
| JOURNAL OF GASTROENTEROLOGY |
2020 | The safety of stopping nucleos(t)ide analogue treatment in patients with HBeAg-negative chronic hepatitis B | LIVER INTERNATIONAL |
2020 | Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission
| LANCET GASTROENTEROLOGY & HEPATOLOGY |
2020 | A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphoma | ANNALS OF HEMATOLOGY |
2020 | Current Status and Future Direction of Immunotherapy in Hepatocellular Carcinoma: What Do the Data Suggest?
| IMMUNE NETWORK |
2020 | The HBeAg-Negative "Gray Zone" Phase: A Frequent Condition With Different Outcomes in Western and Asian Patients? Reply | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2020 | Hepatocellular Carcinoma Risk Steadily Persists Over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION |
2020 | An observational study on long-term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate | JOURNAL OF VIRAL HEPATITIS |
2020 | Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2020 | Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase | CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY |
2019 | Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy
| SCIENTIFIC REPORTS |
2019 | Long-term Outcomes of Antiviral Therapy in Patients With Advanced Chronic HBV Infection | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2019 | Progression of Untreated Minimally Active Chronic HBV Infection Compared to Inactive Infection | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2019 | Long-term Efficacy of Tenofovir Disoproxil Fumarate Monotherapy for Multidrug-Resistant Chronic HBV infection | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2019 | Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
| CLINICAL AND MOLECULAR HEPATOLOGY |
2019 | External validation of the modified PAGE-B score in Asian chronic hepatitis B patients receiving antiviral therapy | LIVER INTERNATIONAL |
2019 | Conditional Survival Estimates Improve Over Time for Patients with Hepatocellular Carcinoma: An Analysis for Nationwide Korea Cancer Registry Database
| CANCER RESEARCH AND TREATMENT |
2019 | Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation
| Cancer Medicine |
2019 | A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea | Journal of Hepatology |
2019 | Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals | CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY |
2019 | Predictors of Discordance in the Assessment of Skeletal Muscle Mass between Computed Tomography and Bioimpedance Analysis
| JOURNAL OF CLINICAL MEDICINE |
2019 | Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals
| SCIENTIFIC REPORTS |
2019 | Fibrosis-matched outcomes between chronic hepatitis B patients with drug-induced virological response and inactive carriers | LIVER INTERNATIONAL |
2018 | A novel risk score for hepatocellular carcinoma in Asian cirrhotic patients: a multicentre prospective cohort study
| SCIENTIFIC REPORTS |
2018 | Long-Term Outcomes of Endoscopic Balloon Dilation for Benign Strictures in Patients with Inflammatory Bowel Disease
| GUT AND LIVER |
2018 | Serotonin signals through a gut-liver axis to regulate hepatic steatosis
| NATURE COMMUNICATIONS |
2018 | Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B | LIVER INTERNATIONAL |
2018 | Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety
| GUT AND LIVER |